Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ABT

Mahindra and Abt operating as a four-car Formula E team, says Biermaier

Abt chief Thomas Biermaier feels his squad and Mahindra are operating as a four-car team as they gear up to compete in Formula E’s Gen3 era together in 2023.

Autosport

Check Out What Whales Are Doing With ABT

Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Check out These 3 Stocks if You Want to Get Rich Over Time

Inflation is still running near the highest levels since 1980, despite Fed’s aggressive efforts to tame it. Although economic uncertainties are rising, staying invested and focusing on long-term strategies could be wise. We believe fundamentally solid stocks Microsoft (MSFT), Abbott Laboratories (ABT), and Kroger (KR) could be ideal buys to…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Rast: We were "never competitive enough" for fourth DTM title

Rene Rast feels he and Audi lacked the pace to win enough DTM races to end the 2022 season as champions amid the series’ Balance of Performance and success ballast systems.

Motorsport

Rast "never competitive enough" for fourth DTM title

Rene Rast feels he and Audi lacked the pace to challenge for a fourth DTM title in 2022 amid the series’ Balance of Performance and success ballast systems.

Autosport

DTM Hockenheim: Auer takes crucial pole for penultimate race

Mercedes driver Lucas Auer clinched a crucial pole position for his DTM championship hopes in Saturday's qualifying session at the Hockenheimring, as Audi star Rene Rast struggled to ninth.

Motorsport

Abbott Laboratories Whale Trades For October 06

A whale with a lot of money to spend has taken a noticeably bullish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories (NYSE:ABT) we detected 10 strange trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

DTM looking to outlaw one-car teams from 2023

The DTM is considering banning one-car teams from taking part in the championship from 2023 due to limited pitlane space at some tracks.

Motorsport

DTM racer Kelvin van der Linde keen to “broaden horizons” beyond GT3

DTM race winner Kelvin van der Linde says he would like to “broaden my horizons” beyond racing GT3 cars after almost a decade in the discipline with Audi.

Motorsport

Mahindra FE principal Gill to depart team ahead of 2022-23 season

Mahindra Formula E principal and CEO Dilbagh Gill will leave the team he has headed up since the championship's very first race in 2014.

Autosport

Mahindra FE boss Gill to depart team ahead of 2022-23 season

Mahindra Formula E principal and CEO Dilbagh Gill will leave the team he has headed up since the championship's very first race in 2014.

Motorsport

DTM racer Kelvin van der Linde keen to “broaden horizons” beyond GT3

DTM race-winner Kelvin van der Linde says he would like to “broaden my horizons” beyond racing GT3 cars after almost a decade in the discipline with Audi.

Autosport

Frijns loss of Formula E form in 2021-22 "90% down to brakes"

Robin Frijns put his loss of form during the 2021-22 Formula E season down to a change in brake material and software, which gradually pulled him out of title contention.

Autosport

4 Stocks Investors Could Hold for the Next Decade

Concerns over the Fed’s continued hawkish stance and a potential recession lead to high market volatility. However, no matter what direction the market follows, quality dividend-paying stocks Microsoft (MSFT), Walmart (WMT), Coca-Cola (KO), and Abbott (ABT) could be great investments for the next decade. Read more….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

5 Dividend Stocks to Buy and Hold Forever

Persistent economic turbulence and an uncertain outlook have led investors to prioritize steady income generation from their investments. Hence, fundamentally sound dividend yielders with a solid track record and potential for perpetual growth Merck (MRK), Abbott (ABT), Cigna (CI), Energy Transfer (ET), and Kronos (KRO) could be permanent additions to…

Autosport

Abt would "trust" Tomczyk to be Berger successor as DTM boss

Abt DTM team principal Thomas Biermaier believes 2011 series champion Martin Tomczyk would be a worthy successor to series boss Gerhard Berger, following an internal reshuffle within organising body ITR.

Sports Illustrated

Janet Rolle is Making History With the American Ballet Theater

As the first Black and first female leader of the prestigious dance company, Janet Rolle is hoping to bring art to the masses.

Benzinga

This Is What Whales Are Betting On Abbott Laboratories

Get all your
news in one place.

100's of premium titles.
One news app.

Autosport

How Audi DTM heavyweights Rast and Muller compare

The GT3-based DTM is a different proposition to the Class 1 era that ended in 2020, but Audi’s top protagonists remain the same. Rivals Rene Rast and Nico Muller have now swapped teams, making their Team Rosberg and Abt engineers uniquely qualified to reveal what makes the pair tick

StockNews.com

5 Stocks With the Most Long-Term Growth Potential

While high inflation and GDP decline for two consecutive quarters are raising recession fears, better-than-expected corporate profits and the possibility of a less aggressive rate hike have been restoring investor confidence. Regardless of the uncertainties surrounding the economy and the market, investing in Abbott Laboratories (ABT), Coca-Cola Consolidated (COKE), DLH…

StockNews.com

The Best Stock to Buy for Long-Term Growth

Healthcare company Abbott Labs (ABT) has demonstrated solid growth over the past years. Moreover, the company announced its plans to restart its baby formula business in Michigan. And considering its fundamental strength, we think the stock might be an ideal investment for long-term growth. Read on….

StockNews.com

Is Abbott Labs A "Strong Buy" After Earnings?

Leading healthcare company Abbott Laboratories (ABT) reported strong second-quarter results. And given the company is well-positioned to capitalize on its diverse business and recent FDA approvals, is it wise to buy the stock now? Let’s find out.

StockNews.com

5 Stocks You'll Want in Your Corner if a Recession Hits

Growing fears over a potential recession due to high inflation and the Federal Reserve’s aggressive interest rate hikes should keep the stock market highly volatile in the upcoming months. However, investors could consider buying relatively stable and dividend-paying stocks Procter & Gamble (PG), AbbVie (ABBV), Abbott (ABT), Caterpillar (CAT), and…

StockNews.com

2 Medical Stocks That Are Attractive Buys Right Now

Amid an inflationary environment, the medical sector is poised to stay afloat given the inelastic demand for medical products and services, impressive breakthroughs, and the rising need to serve an aging population. Therefore, fundamentally sound medical stocks Abbott Laboratories (ABT) and Utah Medical Products (UTMD) could be solid investments right…

StockNews.com

Is Abbott Stock a Buy at $105 as Production in Troubled Plant Resumes?

Leading healthcare company Abbott Laboratories (ABT) reported robust first-quarter results. And the company is well-positioned to benefit from its diversified business. Moreover, as ABT is resuming infant formula production at its Michigan facility, is the stock a good buy at the current price level? Read more to find out….

1 … 9 10 11 12

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.